StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis 1. Oncology by Quarter

1. Oncology ($M)

QuarterlyAnnual

Novartis 1. Oncology: $4,678M in Q3 2026, up 26.4% from a year earlier. That is the highest of the 16 quarters on record here.

Latest, Q3 2026
4,678
Period ended Sep 30, 2026
Change on a year earlier
+26.4%
3,702 in Q3 2025
History
16 quarters
Since Q4 2022
Sources
12
Documents cited below

Where the Q3 2026 figure comes from

“|| Total oncology 4 | 4 678 | 3 702 | 26 | 27”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K (Net sales by therapeutic area) & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEnded1. Oncology ($M)Year on yearSource
Q3 2026Sep 30, 20264,678+26.4%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20264,515+34.7%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20264,021+39.5%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20254,256+11.3%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20253,702-0.5%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20253,353-4.9%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 20252,883-10.6%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20243,824+14.3%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20243,722+13.3%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20243,527+8.9%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 20243,224+8.0%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20233,346+10.6%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20233,284–Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20233,238–Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 20232,984–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20223,025–Novartis Form 6-K (0001370368-24-000007) ↗

Breakdown

What makes up 1. Oncology

Cite this data

StockData. (2026). Novartis 1. Oncology ($M), quarterly Q4 2022–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/ta-oncology

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.